drugset / Trial / NCT01237535

Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates

NCT01237535

Phase 4 Unknown 400 enrolled Rabin Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single center, 3 arms, prospective randomized controlled open study to determine the impact of luteal phase support on pregnancy rates in ovarian stimulation and IUI cycles with recombinant FSH in patients with unexplained infertility and mild male factor. Patients will be randomized into 3 groups: 1. Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel) 2. Luteal support with estrogen + progesterone \[(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg\]. 3. No luteal support

Timeline

Start
2011-11
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 4 mg
Subject Progesterone Other / unclassified 8 % Other

Indications